Vaccines become more attractive to drug developers

11/18/2009 | Google

Vaccines are catching up with prescription drugs as the most lucrative segment of the pharmaceutical business, as more biotech and drug firms invest in vaccine development. GlaxoSmithKline opened a vaccine-packaging plant in Pennsylvania in a bid to topple Merck & Co. as a global leader in vaccine manufacturing, while Johnson & Johnson plans to build a full vaccine portfolio that includes a universal flu shot and a vaccine for Alzheimer's disease.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN